Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Request for ONC to Update Guidance
View:
Post by Journeytc on Jul 11, 2024 2:22pm

Request for ONC to Update Guidance

Im recommending shareholders message ONC on their website requesting update on Breast Cancer upcoming milestones.   The typee C meeting concluded and they have not updated guidance. 
1.  When do rhey expect to file for approval of the phase 3 breast cancer trial?
2.  Are they awaiting additional data or conclusion of the Bracelet trial before doing so?
3.  When do they expect first enrollment in the phase?
4.  What is the target population for the therapeutic?   What does including upto first ADC treatment mean?  Are they expecting to be the frontline treatment of choice?

To message go to oncolytic biotechs website and under contact they give opportunity for inquiry.
Comment by Quentin30 on Jul 11, 2024 3:22pm
something to add to your questions 1) They need to file the trial protocol... should take a couple of months for approval... ONCY must have worked out the potential outcomes ahead of the Type C meeting, and would have had different plans with which to move forward (depending on actual FDA answers)... having heard nothing doesn't sit well with me. ALL meetings with FDA can be considered ...more  
Comment by Azzak34 on Jul 11, 2024 4:19pm
No need to email the company folks, Quenty the portfolio destructor has it all worked out. Make sure you sign up to his newsletter so you can inverse his stock picks. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities